menu
    • menu

    Company profile for Oblique Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Oblique Therapeutics is a privately held biotech company, founded in 2015 in Gothenburg, Sweden. We are committed to finding treatments for severe diseases with large unmet clinical needs such as pain and advanced cancer using our unique angle of a targeted functionality antibody approach. We are driven by curiosity and innovation to develop a solid portfolio based on asset-generation through our game-changing antibody platfor...
    Oblique Therapeutics is a privately held biotech company, founded in 2015 in Gothenburg, Sweden. We are committed to finding treatments for severe diseases with large unmet clinical needs such as pain and advanced cancer using our unique angle of a targeted functionality antibody approach. We are driven by curiosity and innovation to develop a solid portfolio based on asset-generation through our game-changing antibody platform, Abiprot™. Our approach is different: we start with patients and their needs for new medicines. Our goal is to generate novel medicines against any disease-modifying human protein target.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Oblique TherapeuticsSweden Flag
    Country
    Country
    Sweden
    Address
    Address
    Arvid Wallgrens Backe 20 413 46 Göteborg
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://obliquet.com/
    Linkedin
    Linkedin
    https://linkedin.com/company/oblique-therapeutics-ab/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Oblique Therapeutics Advances NaV 1.8 Project To Next Stage
    Oblique Therapeutics Advances NaV 1.8 Project To Next Stage

    22 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/oblique-therapeutics-announces-that-nav-1-8-project-is-advancing-to-next-stage-302282962.html

    PR NEWSWIRE
    22 Oct 2024
    Share Share
    Oblique Therapeutics Partners With Eli Lilly On AbiProt® Technology
    Oblique Therapeutics Partners With Eli Lilly On AbiProt® Technology

    22 Aug 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/oblique-therapeutics-has-entered-a-research-collaboration-agreement-with-eli-lilly-and-company-to-apply-the-abiprot-technology-to-generate-antibodies-to-a-high-value-target-302228545.html

    PR NEWSWIRE
    22 Aug 2024
    Share Share
    Oblique is delighted to announce appointment Christer Nordstedt M.D. PhD. as CEO
    Oblique is delighted to announce appointment Christer Nordstedt M.D. PhD. as CEO

    09 Nov 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/oblique-therapeutics-is-delighted-to-announce-the-appointment-of-christer-nordstedt-md-phd-as-chief-executive-officer-301672680.html

    PRNEWSWIRE
    09 Nov 2022
    Share Share
    Oblique Therapeutics is excited to present the recent progress anti-Thioredoxin
    Oblique Therapeutics is excited to present the recent progress anti-Thioredoxin

    13 Oct 2021

    // BIOSPACE

    https://www.biospace.com/article/releases/oblique-therapeutics-is-excited-to-present-the-recent-progress-on-its-anti-thioredoxin-mab-program-at-the-annual-meeting-of-society-for-immunotherapy-of-cancer-nov-10-14-washington-dc-usa/

    BIOSPACE
    13 Oct 2021
    Share Share
    Oblique announces achievement of key milestone in its aKRAS-mAb program
    Oblique announces achievement of key milestone in its aKRAS-mAb program

    27 Sep 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/oblique-therapeutics-announces-achievement-of-key-milestone-in-its-akras-mab-program-and-abiprot-platform-301386298.html

    PRNEWSWIRE
    27 Sep 2021
    Share Share
    Science Advances publishes proteomics technology from Oblique Therapeutics AB
    Science Advances publishes proteomics technology from Oblique Therapeutics AB

    19 Apr 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/science-advances-publishes-proteomics-technology-from-oblique-therapeutics-ab-with-a-potential-to-bring-several-novel-antibody-medicines-to-large-patient-populations-in-multiple-disease-areas-301271171.html

    PRNEWSWIRE
    19 Apr 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search